Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,090 across all filing types
Latest filing 2022-12-06 M&A Activity
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Horizon Therapeutics PLC
M&A Activity Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used to report dealings in relevant securities by persons with interests in 1% or more of a company involved in a takeover or merger situation. Since this document details specific share transactions, derivatives, and options related to a takeover scenario, it falls under the category of M&A Activity (TAR).
2022-12-06 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 98% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the 'Public Opening Position Disclosure/Dealing Disclosure' by a person with interests in relevant securities representing 1% or more. This type of document is specifically used for major shareholding notifications and disclosures related to takeover activity. Since it does not fit into the specific categories of M&A (which usually refers to the company's own announcements) or Director's Dealing, and is a standard regulatory requirement for market participants, it is classified as a Regulatory Filing (RNS).
2022-12-06 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 100% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the 'Public Opening Position Disclosure/Dealing Disclosure' by a person with interests in relevant securities (Citadel Group) regarding an offeror/offeree (Mediclinic International plc). This type of document is a specific regulatory requirement for M&A activity disclosures and does not fit into the other categories like 10-K, ER, or IP. It is a formal regulatory filing, thus 'RNS' is the most appropriate classification.
2022-12-05 English
Form 8.3 - Horizon Therapeutics PLC
Regulatory Filings Classification · 98% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel rules. This form is used by persons with interests in relevant securities representing 1% or more to disclose dealings in the securities of a company involved in an offer (takeover). While it involves share dealings, it is specifically a regulatory disclosure related to M&A activity (takeover rules). Given the specific nature of these disclosures in the context of takeover panels, it falls under the M&A Activity category.
2022-12-05 English
Form 8.3 - Horizon Therapeutics PLC
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. It details dealings by a person (Citadel Group) with interests in relevant securities of an offeree company (Horizon Therapeutics PLC) during a takeover period. This is a standard regulatory disclosure required during M&A activity to report shareholdings and transactions. Since it is a specific regulatory filing regarding takeover-related disclosures, it falls under the 'Regulatory Filings' category.
2022-12-02 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 98% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the 'Public Opening Position Disclosure/Dealing Disclosure' by a person with interests in relevant securities representing 1% or more of a company (Mediclinic International plc). This type of document is a specific regulatory requirement for transparency during takeover or merger activities. Since it is a formal regulatory disclosure regarding shareholdings and dealings, it falls under the 'Regulatory Filings' category.
2022-12-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.